maribavir (Livtencity)

From Aaushi
Jump to navigation Jump to search

Indications

Drug interactions

Mechanism of action

More general terms

References

  1. FDA News Release. Nov 23, 2021 FDA Approves First Treatment for Common Type of Post-Transplant Infection that is Resistant to Other Drugs. https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-common-type-post-transplant-infection-resistant-other-drugs
  2. Maertens J, Cordonnier C, Jaksch P et al Maribavir for Preemptive Treatment of Cytomegalovirus Reactivation. N Engl J Med 2019; 381:1136-1147 PMID: https://www.ncbi.nlm.nih.gov/pubmed/31532960 https://www.nejm.org/doi/full/10.1056/NEJMoa1714656
  3. Mullard A FDA approves decades-old maribavir for CMV infection. Nature Reviews Drug Discovery. Dec 6, 2021 https://www.nature.com/articles/d41573-021-00208-2
  4. Wikipedia: Maribavir https://en.wikipedia.org/wiki/Maribavir

Database